Biomarker Discovery by Novel Sensors Based on Nanoproteomics Approaches

During the last years, proteomics has facilitated biomarker discovery by coupling high-throughput techniques with novel nanosensors. In the present review, we focus on the study of label-based and label-free detection systems, as well as nanotechnology approaches, indicating their advantages and applications in biomarker discovery. In addition, several disease biomarkers are shown in order to display the clinical importance of the improvement of sensitivity and selectivity by using nanoproteomics approaches as novel sensors.

[1]  Ling Dong,et al.  Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2011, Acta biochimica et biophysica Sinica.

[2]  Pietro Perlo,et al.  Anodic porous alumina as mechanical stability enhancer for LDL-cholesterol sensitive electrodes. , 2007, Biosensors & bioelectronics.

[3]  Qin Guo,et al.  Recent Advances in Nanotechnology Applied to Biosensors , 2009, Sensors.

[4]  F. Mackay,et al.  Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie , 2000, Nature Medicine.

[5]  Patricia Price,et al.  The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. , 2011, Biomarkers in medicine.

[6]  Mahesh Uttamchandani,et al.  Microarray: a versatile platform for high-throughput functional proteomics. , 2006, Combinatorial chemistry & high throughput screening.

[7]  Hui Xia,et al.  Ultra sensitive affinity chromatography on avidin-functionalized PMMA microchip for low abundant post-translational modified protein enrichment , 2012, Biomedical microdevices.

[8]  Gwo-Bin Lee,et al.  An integrated microfluidic system for rapid diagnosis of dengue virus infection , 2009, Biosensors and Bioelectronics.

[9]  Tanya S. Hauck,et al.  Nanotechnology diagnostics for infectious diseases prevalent in developing countries. , 2010, Advanced drug delivery reviews.

[10]  M. Eloubeidi,et al.  Molecular and clinical markers of pancreas cancer. , 2010, JOP : Journal of the pancreas.

[11]  Pietro Perlo,et al.  Nanostructuring of a porous alumina matrix for a biomolecular microarray , 2006 .

[12]  Weidong Zhou,et al.  Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. , 2008, Nano letters.

[13]  Eugenia Pechkova,et al.  Nanoproteomics for nanomedicine. , 2010, Nanomedicine.

[14]  Sanjeeva Srivastava,et al.  Protein microarrays and novel detection platforms , 2011, Expert review of proteomics.

[15]  Joshua LaBaer,et al.  Emerging tools for real‐time label‐free detection of interactions on functional protein microarrays , 2005, The FEBS journal.

[16]  Paul Lizardi,et al.  Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements , 2004, Genome Biology.

[17]  Mi-Ryung Kim,et al.  Proteome analysis of serum from type 2 diabetics with nephropathy. , 2007, Journal of proteome research.

[18]  Marek Piliarik,et al.  Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging , 2009, Analytical and bioanalytical chemistry.

[19]  Changming Mao,et al.  A label-free immunosensor based on modified mesoporous silica for simultaneous determination of tumor markers. , 2011, Biosensors & bioelectronics.

[20]  Eugenia Pechkova,et al.  An overview of nanotechnology-based functional proteomics for cancer and cell cycle progression. , 2010, Anticancer research.

[21]  Y. P. Bao,et al.  Detection of protein analytes via nanoparticle-based bio bar code technology. , 2006, Analytical chemistry.

[22]  Iver Petersen,et al.  Array technology and proteomics in autoimmune diseases. , 2004, Pathology, research and practice.

[23]  Xun Qu,et al.  Biomarker discovery for ovarian cancer using SELDI-TOF-MS. , 2006, Gynecologic oncology.

[24]  V. Kodoyianni.  Label-free analysis of biomolecular interactions using SPR imaging. , 2011, BioTechniques.

[25]  Marye Anne Fox,et al.  Surface effects in water-soluble shell-core hybrid gold nanoparticles in oligonucleotide single strand recognition for sequence-specific bioactivation. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[26]  H. Dai,et al.  Peptide-coated nanotube-based biosensor for the detection of disease-specific autoantibodies in human serum. , 2008, Biosensors & bioelectronics.

[27]  James F Rusling,et al.  Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. , 2011, Biosensors & bioelectronics.

[28]  Manuel Fuentes,et al.  New technologies in cancer. Protein microarrays for biomarker discovery , 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[29]  Akhilesh Pandey,et al.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture , 2008, Nature Protocols.

[30]  Eugenia Pechkova,et al.  Matrices for Sensors from Inorganic, Organic, and Biological Nanocomposites , 2011, Materials.

[31]  Silvana Gaudieri.  Biomarkers that reflect immune activation or dysfunction will be important in the management of infectious diseases. , 2011, Biomarkers in medicine.

[32]  Yi Lu,et al.  Novel diagnostic biomarkers for prostate cancer , 2010, Journal of Cancer.

[33]  David J S Birch,et al.  Nanomedicine and its potential in diabetes research and practice , 2008, Diabetes/metabolism research and reviews.

[34]  Chandra Mohan,et al.  Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. , 2005, The Journal of clinical investigation.

[35]  Wei Huang,et al.  Serum proteomic signature for cystic fibrosis using an antibody microarray platform. , 2006, Molecular genetics and metabolism.

[36]  Sze Chuen Cesar Wong,et al.  Advanced proteomic technologies for cancer biomarker discovery , 2009, Expert review of proteomics.

[37]  Sandro Carrara,et al.  Poly(2,5-dimethylaniline)–MWNTs nanocomposite: a new material for conductometric acid vapours sensor , 2004 .

[38]  Ronald W Davis,et al.  Label-free biosensing with functionalized nanopipette probes , 2009, Proceedings of the National Academy of Sciences.

[39]  Norbert Hampp,et al.  Photoreversibility and photostability in films of octopus rhodopsin isolated from octopus photoreceptor membranes. , 2009, Journal of biomedical materials research. Part A.

[40]  V. Vaidya,et al.  Novel technologies for the discovery and quantitation of biomarkers of toxicity. , 2008, Toxicology.

[41]  Hongjie Dai,et al.  Protein microarrays with carbon nanotubes as multicolor Raman labels , 2008, Nature Biotechnology.

[42]  X Chris Le,et al.  Use of quantum dots in the development of assays for cancer biomarkers , 2010, Analytical and bioanalytical chemistry.

[43]  Eleonora Cerasoli,et al.  MiS-MALDI: microgel-selected detection of protein biomarkers by MALDI-ToF mass spectrometry. , 2010, Molecular bioSystems.

[44]  Jeffrey W. Smith,et al.  Mass Spectrometry-Based Label-Free Quantitative Proteomics , 2009, Journal of biomedicine & biotechnology.

[45]  Richard R Neubig,et al.  Use of Flow Cytometric Methods to Quantify Protein‐Protein Interactions , 2010, Current protocols in cytometry.

[46]  Soyoung Lee,et al.  Application of Novel Quantitative Proteomic Technologies to Identify New Serological Biomarkers in Autoimmune Diseases , 2011 .

[47]  Jiangqin Zhao,et al.  Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles , 2009, Clinical and Vaccine Immunology.

[48]  Paola Torreri,et al.  Biomolecular interactions by Surface Plasmon Resonance technology. , 2005, Annali dell'Istituto superiore di sanita.

[49]  Shuming Nie,et al.  In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots , 2007 .

[50]  David E. Misek,et al.  Protein Biomarkers for the Early Detection of Breast Cancer , 2011, International journal of proteomics.

[51]  A. Vlahou,et al.  Secretome proteomics for discovery of cancer biomarkers. , 2010, Journal of proteomics.

[52]  Manuel Fuentes,et al.  Nanotechniques in proteomics: protein microarrays and novel detection platforms. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[53]  Jesse V Jokerst,et al.  Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. , 2009, Biosensors & bioelectronics.

[54]  Lori J Sokoll,et al.  Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. , 2009, Journal of proteome research.

[55]  J. Vaqué,et al.  Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification. , 2010, Analytical chemistry.

[56]  Kenji Usui,et al.  Protein–protein interactions and selection: array‐based techniques for screening disease‐associated biomarkers in predictive/early diagnosis , 2010, The FEBS journal.

[57]  Robert B. Sim,et al.  Carbon nanotubes for biomedical applications , 2005, IEEE Transactions on NanoBioscience.

[58]  Michael J Sweredoski,et al.  Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research. , 2012, Journal of proteome research.

[59]  David J. Mooney,et al.  Label-free biomarker detection from whole blood , 2009, 2010 10th IEEE International Conference on Solid-State and Integrated Circuit Technology.

[60]  C. Fernández-Lôpez,et al.  Polymorphisms in genes encoding tumor necrosis factor-alpha and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis. , 2008, The Journal of rheumatology.

[61]  D. Goldenberg,et al.  New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  S. Gygi,et al.  Quantitative Cancer Proteomics: Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) as a Tool for Prostate Cancer Research*S , 2004, Molecular & Cellular Proteomics.

[63]  Joshua LaBaer,et al.  Protein microarrays as tools for functional proteomics. , 2005, Current opinion in chemical biology.

[64]  Maxim G Ryadnov,et al.  Nano-enabled biomarker discovery and detection. , 2011, Biomarkers in medicine.

[65]  W. Robinson,et al.  Proteomic biomarkers for autoimmune disease , 2006, Proteomics.

[66]  L. F. Waanders,et al.  Top-down quantitation and characterization of SILAC-labeled proteins , 2007, Journal of the American Society for Mass Spectrometry.

[67]  D. Goodlett,et al.  Advances in proteomic prostate cancer biomarker discovery. , 2010, Journal of proteomics.

[68]  Sanjeeva Srivastava,et al.  Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead , 2011, Proteomics.

[69]  C Nicolini,et al.  Nanostructuring of heme-proteins for biodevice applications. , 2007, IET nanobiotechnology.

[70]  Heather A Clark,et al.  Nanosensors and nanomaterials for monitoring glucose in diabetes. , 2010, Trends in molecular medicine.

[71]  Anders A. Bengtsson,et al.  Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays* , 2011, Molecular & Cellular Proteomics.

[72]  Sandeep Choudhary,et al.  Emerging nanoproteomics approaches for disease biomarker detection: a current perspective. , 2011, Journal of proteomics.

[73]  Joseph Wang.  Carbon‐Nanotube Based Electrochemical Biosensors: A Review , 2005 .

[74]  Jean-Charles Sanchez,et al.  Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt‐Jakob disease , 2004, Proteomics.

[75]  Fridtjof Lund-Johansen,et al.  Antibody Array Analysis with Label-based Detection and Resolution of Protein Size *S , 2009, Molecular & Cellular Proteomics.

[76]  M. Herbster,et al.  Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum , 2006, The Lancet.

[77]  Nishma Gupta,et al.  alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy. , 2010, Journal of medical microbiology.

[78]  Claudio Nicolini,et al.  Bacteriorhodopsin thin film as a sensitive layer for an anaesthetic sensor , 1996 .